Method for producing 3-hydroxypropionic acid and other products

US2019119708A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2019119708-A1
Application numberUS-201816159135-A
CountryUS
Kind codeA1
Filing dateOct 12, 2018
Priority dateSep 27, 2009
Publication dateApr 25, 2019
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This invention relates to metabolically engineered microorganism strains, such as bacterial strains, in which there is an increased utilization of malonyl-CoA for production of a chemical product, which includes 3-hydroxypropionic acid.

First claim

Opening claim text (preview).

1 . (canceled) 2 . A method for producing a product having malonyl-CoA as a substrate in a microbial production pathway of the product, the method comprising combining a carbon source and a microorganism with a cell culture to produce said product, wherein: a) said microorganism is genetically modified for reduced enzymatic activity of an enzyme wherein the enzyme is selected from the group consisting of beta-ketoacyl-ACP synthase, beta-ketoacyl-ACP reductase, beta-hydroxyacyl-ACP dehydratase, and enoyl-ACP reductase; b) the enzymatic activity of the enzyme is reduced after fermentation is initiated; and either: c1) said microorganism is further genetically modified for overexpression of udhA or pntAB; or c2) said microorganism is genetically modified for overexpression of accA, accB, accC, accD, or any combination thereof. 3 . The method of claim 2 , wherein said carbon source is glucose, sucrose, fructose, dextrose, lactose, or a combination thereof. 4 . The method of claim 2 , wherein said microorganism is genetically modified for increased enzymatic activity in the organism's malonyl-CoA reductase (mcr) pathway by introduction of a heterologous nucleic acid sequence coding for a polypeptide having bi-functional malonyl-CoA reductase activity or mono-functional malonyl-CoA reductase activity. 5 . The method of claim 4 , wherein said polypeptide has at least 70% homology with a sequence selected from the group consisting of SEQ ID NOs: 783-789. 6 . The method of claim 2 , wherein said microorganism is further genetically modified for overexpression of udhA or pntAB, and wherein said microorganism is genetically modified for overexpression of accA, accB, accC, accD, or any combination thereof. 7 . The method of claim 2 , wherein said overexpression of udhA or pntAB occurs by introduction of a heterologous nucleic acid sequence having at least 90% homology with a sequence selected from the group consisting of SEQ ID NOs. 886, 779, and 781. 8 . The method of claim 2 , wherein said microorganism is further genetically modified for increased intracellular bicarbonate levels by introduction of a heterologous nucleic acid sequence coding for a polypeptide having cyanase and/or carbonic anhydrase activity. 9 . The method of claim 8 , wherein said heterologous nucleic acid sequence is a sequence having at least 90% homology with SEQ ID NO. 337. 10 . The method of claim 2 , wherein said overexpression of accA, accB, accC, accD, or any combination thereof occurs by introduction of a heterologous nucleic acid sequence coding for a polypeptide having at least 90% homology with a sequence selected from the group consisting of SEQ ID NO. 772, 774, 776, and 778. 11 . The method of claim 2 , wherein said microorganism is further genetically modified to decrease activity of lactate dehydrogenase, phosphate acetyltransferase, pyruvate oxidase, pyruvate-formate lyase, or a combination thereof. 12 . The method of claim 2 , wherein said microorganism cell culture comprises increased intracellular bicarbonate levels by supplementation with bicarbonate or carbonate.

Assignees

Inventors

Classifications

  • Pyruvate dehydrogenase (acetyl-transferring) (1.2.4.1) · CPC title

  • Propionic acid; Butyric acids · CPC title

  • containing a carboxyl group {including Peroxycarboxylic acids} · CPC title

  • C12P11/00Primary

    Preparation of sulfur-containing organic compounds · CPC title

  • Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2019119708A1 cover?
This invention relates to metabolically engineered microorganism strains, such as bacterial strains, in which there is an increased utilization of malonyl-CoA for production of a chemical product, which includes 3-hydroxypropionic acid.
Who is the assignee on this patent?
Cargill Inc, Univ Colorado Regents
What technology area does this patent fall under?
Primary CPC classification C12P11/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Apr 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).